COVID-19 vaccine development: What lessons can we learn from TB?
Abstract At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Vaccine development against SARS-CoV-2 has drawn the global attention in order to stop the spread of t...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2020-11-01
|
| Edice: | Annals of Clinical Microbiology and Antimicrobials |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12941-020-00402-x |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|